See also this year's filing and all EDGAR filings for this company.
PDF Report 0001664710_2026_Keros_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001664710, Keros Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 315,434,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 4,297,000 |
| 3 | remainder_Assets | 18,290,000 |
| 4 | LiabilitiesCurrent | 20,414,000 |
| 5 | LiabilitiesNoncurrent | 14,475,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 62,664,650 |
| 9 | ResearchAndDevelopmentExpense | 89,510,066 |
| 10 | remainder_Expenses | 3,611,864 |
| 11 | remainder_Revenues | 478,278,636 |
| 12 | remainder_NetIncome | 24,874,028 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 338,021,000 |
| 1 | Liabilities | 34,889,000 |
| 2 | Expenses | 155,786,580 |
| 3 | Revenues | 478,278,636 |
| 4 | StockholdersEquity | 303,132,000 |
| 5 | NetIncome | 347,366,084 |
| 6 | ComprehensiveNetIncome | 347,366,084 |
| 7 | BaseVar | 515,924,622 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 5.41 |
| 9 | EconomicCapitalRatio | 5.54 |
Edgar->Model Mapping
Feature Distribution
Change over Time
